Pink Sheets

Neurologix, Inc. is a development-stage company that is engaged in the research and development of treatments for disorders of the brain and central nervous system, using gene transfer and other therapies. The Company’s development efforts are focused on gene transfer for treating Parkinson’s disease. Its core technology, which it refers to as NLX, is in the clinical development stages, and tested in the Phase I and Phase II clinical trials to treat Parkinson’s disease.


One Bridge Plaza One Bridge Plaza
FORT LEE, NJ 07024
United States
+1-201-5926451 (Phone)
+1-201-5920366 (Fax)


Copyright  2011